1. Home
  2. IMTX vs REAL Comparison

IMTX vs REAL Comparison

Compare IMTX & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMTX
  • REAL
  • Stock Information
  • Founded
  • IMTX N/A
  • REAL 2011
  • Country
  • IMTX Germany
  • REAL United States
  • Employees
  • IMTX N/A
  • REAL N/A
  • Industry
  • IMTX Biotechnology: Biological Products (No Diagnostic Substances)
  • REAL Other Specialty Stores
  • Sector
  • IMTX Health Care
  • REAL Consumer Discretionary
  • Exchange
  • IMTX Nasdaq
  • REAL Nasdaq
  • Market Cap
  • IMTX 514.2M
  • REAL 554.6M
  • IPO Year
  • IMTX N/A
  • REAL 2019
  • Fundamental
  • Price
  • IMTX $4.26
  • REAL $5.38
  • Analyst Decision
  • IMTX Strong Buy
  • REAL Buy
  • Analyst Count
  • IMTX 4
  • REAL 6
  • Target Price
  • IMTX $16.67
  • REAL $8.00
  • AVG Volume (30 Days)
  • IMTX 849.5K
  • REAL 3.0M
  • Earning Date
  • IMTX 05-13-2025
  • REAL 05-08-2025
  • Dividend Yield
  • IMTX N/A
  • REAL N/A
  • EPS Growth
  • IMTX N/A
  • REAL N/A
  • EPS
  • IMTX 0.14
  • REAL N/A
  • Revenue
  • IMTX $161,336,577.00
  • REAL $600,484,000.00
  • Revenue This Year
  • IMTX N/A
  • REAL $11.35
  • Revenue Next Year
  • IMTX $18.80
  • REAL $9.35
  • P/E Ratio
  • IMTX $29.39
  • REAL N/A
  • Revenue Growth
  • IMTX 188.60
  • REAL 9.32
  • 52 Week Low
  • IMTX $3.30
  • REAL $2.24
  • 52 Week High
  • IMTX $13.77
  • REAL $11.38
  • Technical
  • Relative Strength Index (RSI)
  • IMTX 48.54
  • REAL 45.88
  • Support Level
  • IMTX $4.03
  • REAL $4.97
  • Resistance Level
  • IMTX $4.48
  • REAL $5.31
  • Average True Range (ATR)
  • IMTX 0.39
  • REAL 0.52
  • MACD
  • IMTX 0.05
  • REAL 0.04
  • Stochastic Oscillator
  • IMTX 75.00
  • REAL 53.85

About IMTX Immatics N.V.

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.

Share on Social Networks: